Skip to main content
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG: 2196)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.54
-0.14 (-0.95%)
Nov 21, 2024, 4:08 PM HKT

Shanghai Fosun Pharmaceutical (Group) Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 10.45B CNY in the quarter ending September 30, 2024, with 12.30% growth. This brings the company's revenue in the last twelve months to 41.61B, down -3.29% year-over-year. In the year 2023, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.40B, down -5.81%.

Revenue (ttm)
41.61B CNY
Revenue Growth
-3.29%
P/S Ratio
n/a
Revenue / Employee
1.03M CNY
Employees
40,370
Market Cap
67.28B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 201928.59B3.67B14.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Shanghai Fosun Pharmaceutical (Group) News

More News